E-Book, Englisch, 800 Seiten, Web PDF
ISBN: 978-0-08-052513-6
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark
Autoren/Hrsg.
Weitere Infos & Material
1;Front Cover;1
2;Rabies;4
3;Copyright Page;5
4;Contents;6
5;Contributors;12
6;Foreword;14
7;Preface ;18
8;Chapter 1. History;20
8.1;I. Text;20
8.2;References ;40
9;Chapter 2. Rabies Virus;42
9.1;I. Introduction ;42
9.2;II. Rabies Virus Structure;44
9.3;III. Intracellular Life Cycle of Rabies Virus;54
9.4;IV. Genome Variability;64
9.5;V. Virus Spread;65
9.6;VI. Molecular Biology of Rabies Virus Proteins;66
9.7;References;80
10;Chapter 3. Molecular Epidemiology;98
10.1;I. Introduction;98
10.2;II. Methods and Definition of Terms;100
10.3;III. Insights: Aspects of Rabies Epidemiology and Pathogenesis Revealed by Molecular Methods of Epidemiologic Investigation ;117
10.4;IV. Conclusions;127
10.5;References;127
11;Chapter 4. Epidemiology;132
11.1;I. Introductory Concepts;133
11.2;II. The Epidemiology of Human Rabies;135
11.3;III. Epidemiology of Rabies in Domestic Animals;145
11.4;IV. Epidemiology of Rabies in Wildlife;154
11.5;V. Epidemiology of Other Lyssaviruses;164
11.6;References;168
12;Chapter 5. Animal Rabies;182
12.1;I. Introduction;182
12.2;II. Host Range;183
12.3;III. Susceptibility and Transmission;184
12.4;IV. Clinical Course ;187
12.5;V. Differential Diagnosis;249
12.6;VI. A Question of Immunity?;192
12.7;VII. Reservoirs and Other Lyssaviruses;193
12.8;VIII. Rabies in Domestic Animals;196
12.9;IX. Wildlife Reservoirs;204
12.10;X. Other Animals as Reservoirs;220
12.11;XI. Conclusions;225
12.12;References;226
13;Chapter 6. Human Disease;238
13.1;I. Introduction;238
13.2;II. Exposures and Incubation Period;239
13.3;III. Clinical Forms of Disease;241
13.4;IV. Investigations;246
13.5;V. Differential Diagnosis;249
13.6;VI. Therapy;251
13.7;VII. Recovery from Rabies;251
13.8;VIII. Rabies due to Other Lyssavirus Genotypes;254
13.9;References;256
14;Chapter 7. Pathogenesis;264
14.1;I. Introduction;265
14.2;II. Events at the Site of Exposure;265
14.3;III. Spread to the CNS;271
14.4;IV. Spread within the CNS;272
14.5;V. Spread from the CNS;273
14.6;VI. Animal Models of Rabies Virus Neurovirulence;275
14.7;VII. Rabies Virus Receptors;279
14.8;VIII. Brain Dysfunction in Rabies;281
14.9;IX. Recovery from Rabies and Chronic Rabies Virus Infection;291
14.10;X. Summary;293
14.11;References;293
15;Chapter 8. Pathology;302
15.1;I. Introduction;302
15.2;II. Histopathology of Rabies Encephalomyelitis;303
15.3;III. Involvement of the Peripheral Nervous System;309
15.4;IV. Involvement of Extraneural Organs;311
15.5;V. Pathology of Paralytic Rabies;312
15.6;VI. Ultrastructural Observations;313
15.7;VII. Conclusions;321
15.8;References;322
16;Chapter 9. Diagnostic Evaluation;326
16.1;I. Introduction;327
16.2;II. Postmortem Diagnosis of Rabies in Animals;328
16.3;III. Virus Isolation;341
16.4;IV. Detection of Viral RNA by Molecular Methods;342
16.5;V. Diagnosis of Rabies in Humans;356
16.6;VI. Rabies Antibody Assays;361
16.7;References;363
17;Chapter 10. Immunology;370
17.1;I. Introduction;370
17.2;II. Molecular Components of a Specific Immune Response;371
17.3;III. Immune Responses during Rabies Virus Infection;372
17.4;IV. Immunologic Basis for Postexposure Vaccination Efficiency;380
17.5;V. Conclusions;383
17.6;References;384
18;Chapter 11. Vaccines;390
18.1;I. Human Rabies Vaccines;391
18.2;II. Rabies Vaccines for Domestic Animals;397
18.3;III. The Next Generation of Rabies Vaccines;404
18.4;References;411
19;Chapter 12. Public Health Management of Humans at Risk;420
19.1;I. Introduction;420
19.2;II. Preexposure Vaccination;423
19.3;III. Postexposure Treatment;428
19.4;IV. Travel to Developing Countries;436
19.5;V. Adverse Reactions to Cell-Culture Vaccines;438
19.6;VI. Interchangeability of Vaccines;438
19.7;VII. Large-Scale Human Exposures;439
19.8;VIII. Rabies Vaccination of Animals;439
19.9;IX. Postexposure Treatment in Developing Countries;440
19.10;References;442
20;Chapter 13. Control of Dog Rabies;448
20.1;I. Introduction;448
20.2;II. History;449
20.3;III. Dog Accessibility: A New Term in Canine Rabies Control;454
20.4;IV. Present Approaches to Dog Rabies Control;456
20.5;V. Significance of Public Awareness and Interdisciplinary Collaboration;458
20.6;VI. Research on Oral Vaccination;459
20.7;VII. Summary;460
20.8;References ;461
21;Chapter 14. Rabies Control in Wildlife;464
21.1;I. The Concept of Controlling Rabies in Wildlife;465
21.2;II. Chiropteran Rabies Control;466
21.3;III. Initiation of Wildlife Rabies Control Programs;466
21.4;IV. Diagnosis of Suspect Wildlife;468
21.5;V. Animal Population Reduction: The First Call for Control;468
21.6;VI. Vector Species Biology, Epidemiology, and Genetics;469
21.7;VII. Transportation of Wildlife;470
21.8;VIII. Oral Rabies Vaccine Development;470
21.9;IX. Vaccine Bait Development;470
21.10;X. Biomarkers;471
21.11;XI. ORV Initiation;473
21.12;XII. Importance of the Home Range of Vector Species in Bait Distribution;474
21.13;XIII. Large-Scale Vaccine Bait Distribution Technology;475
21.14;XIV. Postdrop Surveillance of Target Species;477
21.15;XV. Vaccine Baiting Costs;478
21.16;XVI. Vaccine Baiting Efficiency and Cost Reduction;479
21.17;XVII. Baiting Success Guidelines;480
21.18;XVIII. Modeling;482
21.19;XIX. Program Perpetuation ;483
21.20;References;484
22;Chapter 15. Future Developments and Challenges ;492
22.1;I. Introduction;492
22.2;II. Pathogenesis;493
22.3;III. Epidemiology and Molecular Epidemiology;493
22.4;IV. Prevention of Human Rabies and Control of Animal Rabies;494
22.5;V. Diagnosis and Therapy of Human Disease;496
22.6;VI. Summary;496
22.7;References;497
23;Index;500